Skip to main content
Erschienen in: European Journal of Epidemiology 8/2020

12.08.2020 | COVID-19 | VACCINE HESITANCY Zur Zeit gratis

Vaccine hesitancy: the next challenge in the fight against COVID-19

verfasst von: Amiel A. Dror, Netanel Eisenbach, Shahar Taiber, Nicole G. Morozov, Matti Mizrachi, Asaf Zigron, Samer Srouji, Eyal Sela

Erschienen in: European Journal of Epidemiology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates.
Literatur
1.
Zurück zum Zitat Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576–7.CrossRef Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576–7.CrossRef
2.
Zurück zum Zitat Omer SB, Salmon DA, Orenstein WA, DeHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. NEJM. 2009;360:1981–8.CrossRef Omer SB, Salmon DA, Orenstein WA, DeHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. NEJM. 2009;360:1981–8.CrossRef
4.
Zurück zum Zitat Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.CrossRef Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.CrossRef
5.
Zurück zum Zitat Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis. 2012;25:243–9.CrossRef Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis. 2012;25:243–9.CrossRef
6.
Zurück zum Zitat Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Heal. 2020;4:421.CrossRef Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Heal. 2020;4:421.CrossRef
7.
Zurück zum Zitat Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547–60.CrossRef Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547–60.CrossRef
8.
Zurück zum Zitat Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35:325–30.CrossRef Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35:325–30.CrossRef
9.
Zurück zum Zitat Corey BL, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368:948–50.CrossRef Corey BL, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368:948–50.CrossRef
10.
Zurück zum Zitat Dean NE, Gsell P-S, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, et al. Design of vaccine efficacy trials during public health emergencies. Sci Transl Med. 2019;11:eaat0360.CrossRef Dean NE, Gsell P-S, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, et al. Design of vaccine efficacy trials during public health emergencies. Sci Transl Med. 2019;11:eaat0360.CrossRef
Metadaten
Titel
Vaccine hesitancy: the next challenge in the fight against COVID-19
verfasst von
Amiel A. Dror
Netanel Eisenbach
Shahar Taiber
Nicole G. Morozov
Matti Mizrachi
Asaf Zigron
Samer Srouji
Eyal Sela
Publikationsdatum
12.08.2020
Verlag
Springer Netherlands
Schlagwort
COVID-19
Erschienen in
European Journal of Epidemiology / Ausgabe 8/2020
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-020-00671-y

Weitere Artikel der Ausgabe 8/2020

European Journal of Epidemiology 8/2020 Zur Ausgabe